Peer Review reports
From: Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
| Original Submission | ||
|---|---|---|
| 2 Sep 2020 | Submitted | Original manuscript |
| 17 Oct 2020 | Reviewed | Reviewer Report |
| 7 Nov 2020 | Reviewed | Reviewer Report |
| 17 Dec 2020 | Author responded | Author comments - Sara Ribeirinho-Soares |
| Resubmission - Version 2 | ||
| 17 Dec 2020 | Submitted | Manuscript version 2 |
| 24 Jan 2021 | Reviewed | Reviewer Report |
| 25 Jan 2021 | Reviewed | Reviewer Report |
| 25 Feb 2021 | Author responded | Author comments - Sara Ribeirinho-Soares |
| Resubmission - Version 3 | ||
| 25 Feb 2021 | Submitted | Manuscript version 3 |
| 16 Mar 2021 | Author responded | Author comments - Sara Ribeirinho-Soares |
| Resubmission - Version 4 | ||
| 16 Mar 2021 | Submitted | Manuscript version 4 |
| 17 Mar 2021 | Author responded | Author comments - Sara Ribeirinho-Soares |
| Resubmission - Version 5 | ||
| 17 Mar 2021 | Submitted | Manuscript version 5 |
| Publishing | ||
| 19 Mar 2021 | Editorially accepted | |
| 6 Apr 2021 | Article published | 10.1186/s12885-021-08070-6 |
You can find further information about peer review here.